# Red Cat Holdings, Inc.: financial statements, quarterly

RCAT · Nasdaq · CIK 748268 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rcat.md) · [Financials](/companies/rcat/financials.md) · [Filings](/companies/rcat/filings.md) · [Insiders](/companies/rcat/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rcat/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | Q4 FY2024 (2024-04-30) | period not labelled (2024-06-30) | Q1 FY2025 (2024-07-31) | period not labelled (2024-09-30) | Q2 FY2025 (2024-10-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6.6](/filings/0001641172-25-010350.md) | [6.3 d](/filings/0001628280-26-019861.md) | [3.2](/filings/0001641172-25-024075.md) | [0.9](/filings/0001554795-24-000238.md) | [1.3](/filings/0000748268-25-000010.md) | [1.5](/filings/0001554795-24-000344.md) | [1.6](/filings/0001628280-26-032121.md) | [3.2](/filings/0001628280-26-054368.md) | [9.6](/filings/0000748268-25-000010.md) | [26.2 d](/filings/0001628280-26-019861.md) | [15.5](/filings/0001628280-26-032121.md) | [20.2](/filings/0001628280-26-054368.md) |
| Cost of revenue | $m | [5.5](/filings/0001641172-25-010350.md) | [5.1 d](/filings/0001628280-26-019861.md) | [6.2](/filings/0001641172-25-024075.md) | [3.3](/filings/0001554795-24-000238.md) | [1.7](/filings/0000748268-25-000010.md) | [1.6](/filings/0001554795-24-000344.md) | [2.5](/filings/0001628280-26-032121.md) | [2.8](/filings/0001628280-26-054368.md) | [9.0](/filings/0000748268-25-000010.md) | [25.1 d](/filings/0001628280-26-019861.md) | [13.5](/filings/0001628280-26-032121.md) | [16.9](/filings/0001628280-26-054368.md) |
| Gross profit | $m | [1.1](/filings/0001641172-25-010350.md) | [1.2 d](/filings/0001628280-26-019861.md) | [0.3](/filings/0001641172-25-024075.md) | [(0.5)](/filings/0001554795-24-000238.md) | [(0.4)](/filings/0000748268-25-000010.md) | [(0.0)](/filings/0001554795-24-000344.md) | [(0.9)](/filings/0001628280-26-032121.md) | [0.4](/filings/0001628280-26-054368.md) | [0.6](/filings/0000748268-25-000010.md) | [1.1 d](/filings/0001628280-26-019861.md) | [2.0](/filings/0001628280-26-032121.md) | [3.3](/filings/0001628280-26-054368.md) |
| Research and development | $m | [2.7](/filings/0001641172-25-010350.md) | [1.0 d](/filings/0001628280-26-019861.md) | [0.3](/filings/0001641172-25-024075.md) | [1.6](/filings/0001554795-24-000238.md) | [1.9](/filings/0000748268-25-000010.md) | [2.2](/filings/0001554795-24-000344.md) | [3.4](/filings/0001628280-26-032121.md) | [3.6](/filings/0001628280-26-054368.md) | [6.0](/filings/0000748268-25-000010.md) | [4.9 d](/filings/0001628280-26-019861.md) | [8.0](/filings/0001628280-26-032121.md) | [14.2](/filings/0001628280-26-054368.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(6.0)](/filings/0001641172-25-010350.md) | [(5.3) d](/filings/0001628280-26-019861.md) | [(5.4)](/filings/0001641172-25-024075.md) | [(12.4)](/filings/0001554795-24-000238.md) | [(8.4)](/filings/0000748268-25-000010.md) | [(13.3)](/filings/0001554795-24-000344.md) | [(12.5)](/filings/0001628280-26-032121.md) | [(12.6)](/filings/0001628280-26-054368.md) | [(17.5)](/filings/0000748268-25-000010.md) | [(23.9) d](/filings/0001628280-26-019861.md) | [(27.3)](/filings/0001628280-26-032121.md) | [(38.6)](/filings/0001628280-26-054368.md) |
| Interest expense | $m | not reported | [0.0 d](/filings/0001554795-24-000195.md) | not reported | [(0.0)](/filings/0001554795-24-000238.md) | not reported | [(0.0)](/filings/0001554795-24-000344.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0000748268-25-000010.md) | not reported | [0.0](/filings/0001628280-26-032121.md) | [0.0](/filings/0001628280-26-054368.md) | [0.7](/filings/0000748268-25-000010.md) | [(0.3) d](/filings/0001628280-26-019861.md) | [0.0](/filings/0001628280-26-032121.md) | [0.0](/filings/0001628280-26-054368.md) |
| Net income | $m | [(6.8)](/filings/0000748268-25-000010.md) | [(7.1) d](/filings/0001628280-26-019861.md) | [(8.2)](/filings/0000748268-25-000010.md) | [(12.4)](/filings/0001554795-24-000344.md) | [(12.4)](/filings/0000748268-25-000010.md) | [(13.3)](/filings/0001554795-24-000344.md) | [(23.1)](/filings/0001628280-26-054368.md) | [(13.3)](/filings/0001628280-26-054368.md) | [(16.0)](/filings/0000748268-25-000010.md) | [(19.7) d](/filings/0001628280-26-019861.md) | [(26.6)](/filings/0001628280-26-054368.md) | [(35.3)](/filings/0001628280-26-054368.md) |
| Diluted EPS | $ per share | [(0.09)](/filings/0001641172-25-010350.md) | not reported | [(0.11)](/filings/0001641172-25-024075.md) | not reported | [(0.16)](/filings/0000748268-25-000010.md) | not reported | [(0.27)](/filings/0001628280-26-032121.md) | [(0.15)](/filings/0001628280-26-054368.md) | [(0.16)](/filings/0000748268-25-000010.md) | not reported | [(0.22)](/filings/0001628280-26-032121.md) | [(0.26)](/filings/0001628280-26-054368.md) |
| Basic EPS | $ per share | [(0.09)](/filings/0001641172-25-010350.md) | not reported | [(0.11)](/filings/0001641172-25-024075.md) | not reported | [(0.16)](/filings/0000748268-25-000010.md) | not reported | [(0.27)](/filings/0001628280-26-032121.md) | [(0.15)](/filings/0001628280-26-054368.md) | [(0.16)](/filings/0000748268-25-000010.md) | not reported | [(0.22)](/filings/0001628280-26-032121.md) | [(0.26)](/filings/0001628280-26-054368.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2024 (2024-04-30) | period not labelled (2024-06-30) | Q1 FY2025 (2024-07-31) | period not labelled (2024-09-30) | Q2 FY2025 (2024-10-31) | FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.1](/filings/0001641172-25-001892.md) | not reported | [7.7](/filings/0001554795-24-000238.md) | not reported | [4.6](/filings/0001554795-24-000344.md) | [9.2](/filings/0001628280-26-019861.md) | [7.7](/filings/0001641172-25-010350.md) | [65.9](/filings/0001641172-25-024075.md) | [206](/filings/0000748268-25-000010.md) | [168](/filings/0001628280-26-054368.md) | [132](/filings/0001628280-26-032121.md) | [326](/filings/0001628280-26-054368.md) |
| Current assets | $m | [22.4](/filings/0001641172-25-001892.md) | not reported | [21.5](/filings/0001554795-24-000238.md) | not reported | [20.9](/filings/0001554795-24-000344.md) | [25.8](/filings/0001628280-26-019861.md) | [29.4](/filings/0001641172-25-010350.md) | [91.6](/filings/0001641172-25-024075.md) | [249](/filings/0000748268-25-000010.md) | [227](/filings/0001628280-26-054368.md) | [210](/filings/0001628280-26-032121.md) | [425](/filings/0001628280-26-054368.md) |
| Total assets | $m | [48.5](/filings/0001641172-25-001892.md) | not reported | [38.0](/filings/0001554795-24-000238.md) | not reported | [51.1](/filings/0001554795-24-000344.md) | [55.6](/filings/0001628280-26-019861.md) | [59.7](/filings/0001641172-25-010350.md) | [121](/filings/0001641172-25-024075.md) | [286](/filings/0000748268-25-000010.md) | [274](/filings/0001628280-26-054368.md) | [282](/filings/0001628280-26-032121.md) | [527](/filings/0001628280-26-054368.md) |
| Current liabilities | $m | [3.7](/filings/0001641172-25-001892.md) | not reported | [4.2](/filings/0001554795-24-000238.md) | not reported | [14.7](/filings/0001554795-24-000344.md) | [4.2](/filings/0001628280-26-019861.md) | [28.9](/filings/0001641172-25-010350.md) | [24.1](/filings/0001641172-25-024075.md) | [23.9](/filings/0000748268-25-000010.md) | [14.8](/filings/0001628280-26-054368.md) | [19.1](/filings/0001628280-26-032121.md) | [28.6](/filings/0001628280-26-054368.md) |
| Total liabilities | $m | [5.0](/filings/0001641172-25-001892.md) | not reported | not reported | not reported | [24.1](/filings/0001554795-24-000344.md) | [5.5](/filings/0001628280-26-019861.md) | [30.7](/filings/0001641172-25-010350.md) | [25.8](/filings/0001641172-25-024075.md) | [32.8](/filings/0000748268-25-000010.md) | [27.8](/filings/0001628280-26-054368.md) | [43.1](/filings/0001628280-26-032121.md) | [56.3](/filings/0001628280-26-054368.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.4](/filings/0001628280-26-032121.md) | [0.9](/filings/0001628280-26-054368.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [0.8](/filings/0001641172-25-001892.md) | not reported | [0.6](/filings/0001554795-24-000238.md) | not reported | [0.4](/filings/0001554795-24-000344.md) | [0.4](/filings/0001628280-26-019861.md) | [0.4](/filings/0001641172-25-010350.md) | [0.4](/filings/0001641172-25-024075.md) | [0.4](/filings/0000748268-25-000010.md) | [0.4](/filings/0001628280-26-054368.md) | [0.4](/filings/0001628280-26-032121.md) | [0.9](/filings/0001628280-26-054368.md) |
| Shareholders' equity | $m | [43.6](/filings/0001628280-26-019861.md) | [38.4](/filings/0000748268-25-000010.md) | [32.5](/filings/0001554795-24-000344.md) | [33.8](/filings/0000748268-25-000010.md) | [27.0](/filings/0001554795-24-000344.md) | [50.1](/filings/0001628280-26-054368.md) | [28.9](/filings/0001628280-26-054368.md) | [95.6](/filings/0001628280-26-054368.md) | [253](/filings/0000748268-25-000010.md) | [246](/filings/0001628280-26-054368.md) | [239](/filings/0001628280-26-054368.md) | [471](/filings/0001628280-26-054368.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | Q4 FY2024 (2024-04-30) | period not labelled (2024-06-30) | Q1 FY2025 (2024-07-31) | period not labelled (2024-09-30) | Q2 FY2025 (2024-10-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(4.4)](/filings/0001641172-25-010350.md) | [(2.4) d](/filings/0001628280-26-019861.md) | [(2.2) d](/filings/0001641172-25-024075.md) | [(2.3)](/filings/0001554795-24-000238.md) | [(8.1) d](/filings/0000748268-25-000010.md) | [(10.1) d](/filings/0001554795-24-000344.md) | [(15.9)](/filings/0001628280-26-032121.md) | [(12.9) d](/filings/0001628280-26-054368.md) | [(23.9) d](/filings/0000748268-25-000010.md) | [(36.5) d](/filings/0001628280-26-019861.md) | [(31.9)](/filings/0001628280-26-032121.md) | [(46.8) d](/filings/0001628280-26-054368.md) |
| Capital expenditure | $m | [0.1](/filings/0001641172-25-010350.md) | [0.1 d](/filings/0001628280-26-019861.md) | [0.0 d](/filings/0001641172-25-024075.md) | [0.1](/filings/0001554795-24-000238.md) | [0.1 d](/filings/0000748268-25-000010.md) | [0.0 d](/filings/0001554795-24-000344.md) | [0.3](/filings/0001628280-26-032121.md) | [0.3 d](/filings/0001628280-26-054368.md) | [0.7 d](/filings/0000748268-25-000010.md) | [5.4 d](/filings/0001628280-26-019861.md) | [6.8](/filings/0001628280-26-032121.md) | [5.8 d](/filings/0001628280-26-054368.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations, us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | Q3 FY2017 (2017-09-30) | period not labelled (2018-03-31) | Q2 FY2018 (2018-06-30) | Q3 FY2018 (2018-09-30) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [47.3](/filings/0001554795-18-000345.md) | [114](/filings/0001554795-18-000141.md) | [202](/filings/0001554795-18-000224.md) | [234](/filings/0001554795-18-000345.md) | [74.2](/filings/0001641172-25-010350.md) | [74.2](/filings/0001641172-25-024075.md) | [75.7](/filings/0000748268-25-000010.md) | [85.5](/filings/0001628280-26-032121.md) | [91.3](/filings/0001628280-26-054368.md) | [99.6](/filings/0000748268-25-000010.md) | [121](/filings/0001628280-26-032121.md) | [137](/filings/0001628280-26-054368.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 152,714,362 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054368.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.